Search results
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
- Ann Marshak-Rothstein
- Perelman School of Medicine at the University of Pennsylvania
- September 7, 1959 (age 64), Lexington, Massachusetts, U.S.
Dr. Weissman is a Nobel laureate for his contributions to mRNA vaccine technology against COVID-19. He is also a leading expert in RNA biology, HIV immunology, and gene therapy at Penn Medicine.
Drew Weissman is a physician-scientist and professor at the University of Pennsylvania who discovered a novel nucleoside-modified mRNA platform for vaccines and therapeutics. He is the co-recipient of the 2023 Nobel Prize in Medicine for his contributions to mRNA research and the development of COVID-19 vaccines.
Dr. Weissman is a renowned physician and researcher who invented the modified mRNA technology for COVID-19 vaccines. He and his team are also working on other mRNA vaccines and therapeutics for coronaviruses, flu, herpes, and cancer.
Oct 2, 2023 · Katalin Karikó and Drew Weissman, Penn’s historic mRNA vaccine research team, win 2023 Nobel Prize in Medicine. The highest honor was bestowed for foundational discoveries that gave the world a vaccine to fight the COVID-19 pandemic. Katalin Karikó and Drew Weissman are the recipients of the 2023 Nobel Prize in Medicine.
Oct 2, 2023 · Katalin Karikó and Drew Weissman, who together identified a chemical tweak to messenger RNA, were awarded the Nobel Prize in Physiology or Medicine on Monday. Their work enabled potent Covid...
People also ask
Why did Katalin Karikó and drew Weissman win a Nobel Prize?
Who is drew Weissman?
Who is Dr Weissman?
What education does Dr Weissman have?
Drew Weissman is a professor of medicine and director of vaccine research at the University of Pennsylvania. He studies RNA and innate immune system biology and develops mRNA-based vaccines for HIV, Lyme disease, SARS-CoV-2 and malaria.
